• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戊巴比妥抑制小脑细胞中由 kainic 酸或 N-甲基-D-天冬氨酸诱导的 cGMP 增强的相对效力。

The relative potency of pentobarbital in suppressing the kainic acid- or the N-methyl-D-aspartic acid-induced enhancement of cGMP in cerebellar cells.

作者信息

Morgan W W, Bermudez J, Chang X Y

机构信息

Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio 78284-7762.

出版信息

Eur J Pharmacol. 1991 Nov 12;204(3):335-8. doi: 10.1016/0014-2999(91)90861-j.

DOI:10.1016/0014-2999(91)90861-j
PMID:1663461
Abstract

Primary cultures of rat cerebellar cells were pretreated with various dosages of pentobarbital before the addition of kainic acid or N-methyl-D-aspartic acid in order to assess effects of this drug on the enhancement of cyclic guanosine-3',5'-phosphate (cyclic GMP) mediated by these excitatory agonists. Pentobarbital significantly suppressed kainic acid-induced increases in this cyclic nucleotide at concentrations as low as 5 microM but was only effective in suppressing the N-methyl-D-aspartic acid enhancement at dosages of 100 microM or greater. These data suggest that this barbiturate is a more effective depressant of the stimulatory effects of kainic acid as compared to N-methyl-D-aspartic acid.

摘要

在添加海藻酸或N-甲基-D-天冬氨酸之前,先用不同剂量的戊巴比妥预处理大鼠小脑细胞原代培养物,以评估该药物对这些兴奋性激动剂介导的环磷酸鸟苷(cGMP)增强作用的影响。戊巴比妥在低至5 microM的浓度下就能显著抑制海藻酸诱导的这种环核苷酸增加,但仅在100 microM或更高剂量时才能有效抑制N-甲基-D-天冬氨酸的增强作用。这些数据表明,与N-甲基-D-天冬氨酸相比,这种巴比妥类药物对海藻酸刺激作用的抑制效果更有效。

相似文献

1
The relative potency of pentobarbital in suppressing the kainic acid- or the N-methyl-D-aspartic acid-induced enhancement of cGMP in cerebellar cells.戊巴比妥抑制小脑细胞中由 kainic 酸或 N-甲基-D-天冬氨酸诱导的 cGMP 增强的相对效力。
Eur J Pharmacol. 1991 Nov 12;204(3):335-8. doi: 10.1016/0014-2999(91)90861-j.
2
Cultured cerebellar cells as an in vitro model of excitatory amino acid receptor function.培养的小脑细胞作为兴奋性氨基酸受体功能的体外模型。
Brain Res. 1987 Aug 11;417(2):380-4. doi: 10.1016/0006-8993(87)90469-0.
3
Novel kainic acid analogues. Effects on cyclic GMP content of adult rat cerebellar slices.新型海人酸类似物。对成年大鼠小脑切片环鸟苷酸含量的影响。
Biochem Pharmacol. 1986 Feb 1;35(3):409-15. doi: 10.1016/0006-2952(86)90213-3.
4
NMDA-, but not kainate- or quisqualate-dependent increases in cerebellar cGMP are dependent upon monoaminergic innervation.小脑环磷酸鸟苷(cGMP)依赖N-甲基-D-天冬氨酸(NMDA)而非红藻氨酸或使君子氨酸的增加,取决于单胺能神经支配。
Life Sci. 1992;51(26):PL267-70. doi: 10.1016/0024-3205(92)90163-j.
5
Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.新型AMPA受体拮抗剂十氢异喹啉-3-羧酸一水合物对大鼠皮质和小脑颗粒神经元中谷氨酸诱导的Ca2+反应及神经毒性的影响。
Biochem Pharmacol. 1995 Nov 27;50(11):1761-74. doi: 10.1016/0006-2952(95)02032-2.
6
Increased response of cerebellar cGMP to kainate but not NMDA or quisqualate following barbital withdrawal from dependent rats.在巴比妥类药物依赖大鼠戒断后,小脑环磷酸鸟苷(cGMP)对海藻酸的反应增强,但对N-甲基-D-天冬氨酸(NMDA)或quisqualate无此反应。
Eur J Pharmacol. 1989 Dec 7;173(2-3):127-32. doi: 10.1016/0014-2999(89)90509-8.
7
Quisqualic acid modulates kainate responses in cultured cerebellar granule cells.使君子氨酸调节培养的小脑颗粒细胞中的红藻氨酸反应。
J Neurochem. 1989 Jan;52(1):10-6. doi: 10.1111/j.1471-4159.1989.tb10891.x.
8
Use-dependent pentobarbital block of kainate and quisqualate currents.海人藻酸和使君子氨酸电流的使用依赖性戊巴比妥阻断
Brain Res. 1993 Apr 9;608(1):7-15. doi: 10.1016/0006-8993(93)90766-g.
9
Excitatory amino acid signal transduction in cerebellar cell cultures.
Funct Neurol. 1986 Oct-Dec;1(4):345-9.
10
Acute, chronic and differential effects of several anesthetic barbiturates on glutamate receptor activation in neuronal culture.几种麻醉性巴比妥类药物对神经元培养物中谷氨酸受体激活的急性、慢性及差异效应。
Brain Res. 1993 May 21;611(2):181-6. doi: 10.1016/0006-8993(93)90501-d.

引用本文的文献

1
Early prediction of neurological outcome after barbiturate coma therapy in patients undergoing brain tumor surgery.脑肿瘤手术患者行巴比妥酸盐昏迷治疗后神经功能转归的早期预测。
PLoS One. 2019 Apr 17;14(4):e0215280. doi: 10.1371/journal.pone.0215280. eCollection 2019.
2
A Fatal Adverse Effect of Barbiturate Coma Therapy: Dyskalemia.巴比妥类药物昏迷疗法的一种致命不良反应:血钾异常。
Korean J Neurotrauma. 2016 Oct;12(2):156-158. doi: 10.13004/kjnt.2016.12.2.156. Epub 2016 Oct 31.
3
The effect of barbiturate coma therapy for the patients with severe intracranial hypertension: a 10-year experience.
巴比妥类药物昏迷疗法对重症颅内高压患者的疗效:十年经验
J Korean Neurosurg Soc. 2008 Sep;44(3):141-5. doi: 10.3340/jkns.2008.44.3.141. Epub 2008 Sep 30.
4
Changes in NMDAR2 subunit mRNA levels during pentobarbital tolerance/withdrawal in the rat brain: an in situ hybridization study.大鼠脑内戊巴比妥耐受/戒断过程中NMDAR2亚基mRNA水平的变化:一项原位杂交研究
Neurochem Res. 1998 Nov;23(11):1371-7. doi: 10.1023/a:1020746505854.
5
Role of NMDA receptors in pentobarbital tolerance/dependence.N-甲基-D-天冬氨酸受体在戊巴比妥耐受性/依赖性中的作用。
Neurochem Res. 1997 Jul;22(7):767-74. doi: 10.1023/a:1022019423197.